MedDataX Logo

Evaluation of Platelet Function in Pregnancy With Multiple Electrode Aggregometry

NCT ID: NCT01881698

Last Updated: 2013-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-10-31

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Establishment of a range of normal values in pregnancy with the Multiple Electrode Aggregometry (Multiplate@) device, a device that allows measurement of not only platelet count but platelet function. This has not been studied in ths special patient group. Results from this trial will be used as a basis for further investigation of abnormal platelet function in pregnancy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Platelet Function Pregnancy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

pregnancy platelet function monitoring multiple electrode aggregometry

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Platelet function during pregnancy Multiple Electrode Aggregometry (Multiplate@) device

Observation of platelet function in pregnancy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnancy

Exclusion Criteria

* Rejection of informed consent
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Reinhard Hahn

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Reinhard Hahn, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Anaesthesia, General Intensive Care and Pain Management, Medical University Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitätsklinik für Frauenheilkunde, Allgemeines Krankenhaus der Stadt Wien

Vienna, Vienna, Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Reinhard Hahn, MD

Role: CONTACT

Phone: 0043 1 40400

Email: [email protected]

Albert M de Bettignies

Role: CONTACT

Phone: 0043 1 40400

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1426/2013

Identifier Type: -

Identifier Source: org_study_id